相关实验视频

Updated: Feb 1, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

针对受氨酸反应的INOS抑制聚合原药,用于向血管生成的抑制

Houman Alimoradi^1,2, Anita Fallah³, Pascale Jespers^4,5

¹Laboratory of Pathophysiological and Nutritional Biochemistry (LPNB), Faculty of Medicine, Université Libre de Bruxelles, 808 Route de Lennik, Blg G/E CP 611, Brussels, 1070, Belgium. houman.alimoradi@ulb.be.

Journal of nanobiotechnology

|January 31, 2026

概括

我们开发了一种新型纳米粒子,该纳米粒子在响应瘤微环境条件时释放可诱导的氧化合成酶 (iNOS) 抑制剂. 这种有针对性的方法显示了治疗癌症相关血管生成的希望,通过使血管正常化.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症治疗方法癌症治疗方法

背景情况:

诱导性氧化合成酶 (iNOS) 在癌症和炎症条件下驱动异常血管生成.
目前的iNOS抑制剂面临着药理动力学和选择性方面的挑战.
针对iNOS和免疫信号的组合方法对于癌症治疗至关重要.

研究的目的:

开发一种对谷氨 (GSH) 敏感的聚合物前药物系统,用于向的iNOS抑制.
为控制药物释放和iNOS对抗创造双重功能纳米粒子 (NPBeS).
评估开发系统的抗血管和血管正常化效应.

主要方法:

开发一种具有GSH反应的INOS抑制聚合物前药物 (GRIP),用甲糖酸盐 (NPBeS) 装饰.
对NPBeS有效载荷释放的评估,以应对升高的GSH水平.
通过抑制巨细胞中氧化 (NO) 生产来评估iNOS抑制.
通过VEGF介导管形成,纤维细胞迁移和CAM试验分析抗血管性活性.
在大鼠大动脉血管扩张中,对内皮氧化合成酶 (eNOS) 功能的保存进行测试.

主要成果:

NPBeS证明了选择性有效载荷释放,以应对瘤微环境 (TME) 具有特征的高GSH水平.
激活的NPBeS有效地抑制了iNOS,减少了NO的产生,并使VEGF驱动的血管生成正常化.
这些纳米颗粒在体外和体内表现出抗血管性活性 (CAM测定).
最重要的是,NPBeS保留了乙胆 (ACh) 诱导的血管扩张,这表明正常的eNOS功能没有受损.

结论:

这项研究引入了第一个GSH响应性前药物系统,用于控制释放和in situ iNOS抗剂合成.
双重作用平台实现了有针对性的,持续的抗血管生成效应,并促进了血管正常化.
这种新型的双功能纳米粒子系统具有治疗癌症相关血管生成的巨大潜力.

关键词:

血管新生的产生.一种对谷氨酸产生反应的前药物.氧化氧化是什么?瘤微环境是一个微环境.我们的 iNOS iNOS

更多相关视频

Online Transcranial Magnetic Stimulation Protocol for Measuring Cortical Physiology Associated with Response Inhibition

Online Transcranial Magnetic Stimulation Protocol for Measuring Cortical Physiology Associated with Response Inhibition

Published on: February 8, 2018

Measuring Glutathione-induced Feeding Response in Hydra

Measuring Glutathione-induced Feeding Response in Hydra

Published on: November 16, 2014

相关概念视频

Feedback Inhibition

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!

Enzyme Inhibition

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Prodrugs

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...

Target Cell Response to Hormones

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...